ACI's Women Leaders in Life Sciences Law conference will feature an exclusive Fireside Chat with the esteemed Martine Rothblatt, PhD, CEO of United Therapeutics. https://goo.gl/0jsLpO
In addition, the program features M&A strategies for all practice areas, tips for getting ahead in the public and private sectors and so much more https://goo.gl/0jsLpO
Gain Concrete Tools for Success at ACI's Women Leaders in Life Sciences Law C...Dyan Cornacchio
www.AmericanConference.com/LSWomen
This conference brings together in house and private practice professionals from the Pharmaceutical, Biotechnology, and Medical Device industries, well-versed in patents, IP, fraud and abuse compliance/enforcement, products liability, regulatory, M&A, and transactional law, and more providing most conducive setting for networking and career development between female legal, business, and compliance professionals.
This document summarizes the agenda for the 3rd Annual 10x Medical Device Conference taking place from May 4-6, 2015 in San Diego. The conference will feature presentations and panels on topics such as marketing and sales strategies, preparing FDA 510(k) submissions, global market access, medical device software and 62304 guidance, and how to sell medical devices in the current healthcare environment. There will also be a keynote presentation from life sciences executive Rhonda Rhyne and opportunities for networking, including a manufacturers showcase and welcome reception on the first night. Over 100 medical device professionals from around the world are expected to attend the conference.
Pharmacy Essay Examples – Telegraph. How to Write Personal Essay for Pharmacy School - YouTube. Pharmacy School Admission Essay Example - Pharmacy Essay. pharmacology essay | Pharmacology | Pharmaceutical Drug | Free 30-day .... Sample personal essays for pharmacy school - technicalcollege.web.fc2.com.
Pharmacy Essay Examples – Telegraph. How to Write Personal Essay for Pharmacy School - YouTube. Pharmacy School Admission Essay Example - Pharmacy Essay. pharmacology essay | Pharmacology | Pharmaceutical Drug | Free 30-day .... Sample personal essays for pharmacy school - technicalcollege.web.fc2.com.
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Len Starnes
First presented at Digital Pharma Europe, Barcelona, 31st March 2009.
Captures the current status of healthcare professionals' social networks from a global perspective and a pharmaceutical industry marketing & sales perspective
This document discusses the rise of social networks for healthcare professionals and its implications for pharmaceutical marketing. It outlines how Sermo was one of the first such networks, with over 100,000 members. Such networks are now global in scope, with varied business models and levels of pharmaceutical industry participation. Key learnings include the interest from healthcare professionals in using social networks and interacting with industry. The document predicts that by 2020, social networks will be ubiquitous among healthcare professionals and will transform pharmaceutical marketing into a more dialogue-based approach with less reliance on sales representatives.
Gain Concrete Tools for Success at ACI's Women Leaders in Life Sciences Law C...Dyan Cornacchio
www.AmericanConference.com/LSWomen
This conference brings together in house and private practice professionals from the Pharmaceutical, Biotechnology, and Medical Device industries, well-versed in patents, IP, fraud and abuse compliance/enforcement, products liability, regulatory, M&A, and transactional law, and more providing most conducive setting for networking and career development between female legal, business, and compliance professionals.
This document summarizes the agenda for the 3rd Annual 10x Medical Device Conference taking place from May 4-6, 2015 in San Diego. The conference will feature presentations and panels on topics such as marketing and sales strategies, preparing FDA 510(k) submissions, global market access, medical device software and 62304 guidance, and how to sell medical devices in the current healthcare environment. There will also be a keynote presentation from life sciences executive Rhonda Rhyne and opportunities for networking, including a manufacturers showcase and welcome reception on the first night. Over 100 medical device professionals from around the world are expected to attend the conference.
Pharmacy Essay Examples – Telegraph. How to Write Personal Essay for Pharmacy School - YouTube. Pharmacy School Admission Essay Example - Pharmacy Essay. pharmacology essay | Pharmacology | Pharmaceutical Drug | Free 30-day .... Sample personal essays for pharmacy school - technicalcollege.web.fc2.com.
Pharmacy Essay Examples – Telegraph. How to Write Personal Essay for Pharmacy School - YouTube. Pharmacy School Admission Essay Example - Pharmacy Essay. pharmacology essay | Pharmacology | Pharmaceutical Drug | Free 30-day .... Sample personal essays for pharmacy school - technicalcollege.web.fc2.com.
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Len Starnes
First presented at Digital Pharma Europe, Barcelona, 31st March 2009.
Captures the current status of healthcare professionals' social networks from a global perspective and a pharmaceutical industry marketing & sales perspective
This document discusses the rise of social networks for healthcare professionals and its implications for pharmaceutical marketing. It outlines how Sermo was one of the first such networks, with over 100,000 members. Such networks are now global in scope, with varied business models and levels of pharmaceutical industry participation. Key learnings include the interest from healthcare professionals in using social networks and interacting with industry. The document predicts that by 2020, social networks will be ubiquitous among healthcare professionals and will transform pharmaceutical marketing into a more dialogue-based approach with less reliance on sales representatives.
1. The document discusses gender diversity and equality in global companies using Merck as a case study. It examines the business case and evidence for promoting women in leadership and the workforce.
2. Data on women's representation in Merck's regions, industries, and roles is presented. Challenges and best practices are outlined around setting goals, understanding drivers of representation, and engaging both men and women.
3. The discussion focuses on internal priorities like culture, development, and flexibility, as well as external stakeholders and customers, with the goal of enhancing inclusion and accelerating women's leadership development.
A panel discussion on how to stop declining female sex ratioArchana Tandon
The document discusses a panel discussion on declining female sex ratio in India. It provides biographies of four panelists: Dr. Archana Tandon, Dr. Kusum Singhal, Dr. Charu Rawat Mittal, and Dr. Kusumlata Singhal. It outlines their educational qualifications and experience in obstetrics and gynecology. The panelists will discuss major causes of declining female sex ratio such as female feticide and infanticide. They will also contemplate why society does not want female children and how these problems can be addressed.
Making your way in the new pharma and biotech world - Sept 2010Jeffrey Boily
A panel of industry experts take a look at how you can survive in the
future world of pharma, especially if you've found yourself stranded at the manager
or director level.
This document profiles Jenny Lin, the COO and Board Director of CMIC, Inc. With over 25 years of experience in executive management and laboratory operations supporting drug research, Jenny has authored over 30 publications. As COO of CMIC, Jenny emphasizes that talent management is key to their success and that people are the most important asset of any business. CMIC delivers bioanalysis services for small molecules, large molecules, biomarkers and oligonucleotides in a flexible manner, ensuring high-quality data through diligent training and an excellent lab environment.
Introduce Yourself to the Company - Writing About Myself Sample and .... Business Essay | Essay on Business for Students and Children in English .... Best Essay Writing Company. Essay writing business. Essay on community service in high school / silkstudio.com.au. A Comprehensive Guide to Write a business essay - YouTube. Do you underline company names in an MLA-style essay? - Quora - How to .... Business essay examples. Business Essay 19/20 | Year 11 HSC - Business Studies | Thinkswap. Essay writing company reviews are the key inductions to select a good…. 002 Job Application Essay Template Sample Teaching ~ Thatsnotus. Tips to find Write my Essay Company. Standard Essay Format | ... Poster Company” Essay Format The following .... Business essay format example. Essay writing company. Features of best essay writing company. Employment Essay. Essay writing company reviews and comments - stntunsw.web.fc2.com. Business essay. Expository essay: How to begin a business essay. business essays samples - News. Business Essay Sample — Understanding Global Business. Best Essay Company. Professional essay writing company London UK quick essay writers — ww…. Custom essay writing company Durham | ThesisEssay76 - (2021). Frightening Essay Writing Company ~ Thatsnotus.
SGA Talent Present Women Leader From The Top BioTech & Pharma Companies. SGA Talent
This report is limited to only a few women leaders identified in a recent study SGA Talent completed last year. The comprehensive study was to identify, map, and profile leaders in the Biotechnology and Pharmaceutical Industries three levels down from the executive teams. It required the SGA Talent team to create organization charts, compare/contrast all identified to their peers, gather salary information and show diversity and inclusion metrics.
If you are looking for talent or intelligence in these industries, give us a call 518 843-4611.
This document summarizes a conference on pharmaceutical and medical device compliance in Latin America being held in Panama City, Panama from August 23-25, 2016. The conference will address critical challenges in the region related to corruption, bribery, and transparency. It will feature panels, keynote addresses, and breakout sessions on topics like compliance priorities, balancing sales and compliance, and interacting with healthcare professionals. Over 50 industry speakers from Latin America, the US, and Europe will participate. The conference is aimed at upgrading compliance programs amid increasing regulation in Latin America's growing pharmaceutical and medical device sectors.
Different hats, same needs: Marketing compliance from doctor’s office to boar...Prolifiq Software
This document discusses the need for good promotional practices across different constituencies in the healthcare industry. It begins by outlining what doctors, companies, and board members want, which is largely reliable information, sales, and avoiding issues. The document then provides four actionable strategies for implementing good promotional practices: 1) Transforming sales reps into information concierges, 2) Using content management systems, 3) Implementing good promotional practices, and 4) Forming and supporting initiatives to bridge information gaps. It emphasizes that good promotional practices protect all parties and should be systematically institutionalized.
SGA Talent Presents The Key Players In The Medical Device IndustrySGA Talent
Since inception, SGA Talent has been helping organizations build more inclusive work places by continuously promoting and emphasizing the need to require both talent pools and candidate pipelines include diversity. We believe part of our responsibility to our partners is to continuously remind them that workplace diversity starts with hiring and the importance of including diversity as part of their overall recruiting strategy. That said, as we continue with our mission we carry on with building and maintaining engaged talent communities that include diversity. Part of doing this includes building our knowledge base of industry leading companies and the talent in the many industries in which we compete, always highlighting women. Part of our strategy is to create monthly industry reports to help with achieving our goals. This month’s report focuses on the Medical Device Industry.
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREADPinky Fadullon
This document provides information about the 6th Annual Global Orphan Drug Conference and Expo taking place April 21-22, 2016 in Washington D.C. The conference will bring together stakeholders in the orphan drug industry including pharmaceutical companies, patient advocacy groups, regulators, payers, and investors. It will include keynote sessions, workshops on topics like market forecasting and commercialization, and networking opportunities. A pre-conference day of workshops is scheduled for April 20th.
The document announces the Pharmaceutical Leadership Summit 2010 conference to be held on June 25-26, 2010 in Mumbai, India. It will bring together leaders from top pharmaceutical companies to discuss important topics facing the industry such as healthcare reforms, marketing strategies, research and development, and building leadership. The summit aims to provide networking opportunities and insights from senior executives on tackling challenges in the evolving pharmaceutical landscape. It promises high-profile speakers from the government and major companies over the two-day agenda covering issues critical to pharmaceutical leadership.
The document announces the Pharmaceutical Leadership Summit 2010 conference to be held on June 25-26, 2010 in Mumbai, India. It will bring together over 60 speakers from top pharmaceutical companies to discuss important topics facing the industry such as healthcare reforms, leadership, innovation, marketing strategies, and opportunities in biotech. The two-day agenda outlines various keynote speeches and panel discussions to be delivered by industry experts and government leaders on these pivotal issues. The summit aims to provide networking opportunities and insights on best practices to help pharmaceutical professionals tackle challenges and guide their organizations successfully.
This document summarizes a webinar presented by the American Sustainable Business Council (ASBC) on the business case for a single-payer "Medicare for All" healthcare system in the United States. The webinar discusses the economic benefits of a single-payer system compared to the current multi-payer system, highlighting analyses showing that a single-payer system would lower overall healthcare costs while improving outcomes. Experts on the webinar address criticisms of single-payer and explain why the U.S. has not adopted such a system previously, noting the significant financial interests of private insurers and others that benefit from the current inefficient approach. The webinar aims to make the economic argument for why single-
This document summarizes a webinar presented by the American Sustainable Business Council (ASBC) on the business case for a single-payer "Medicare for All" healthcare system in the United States. The webinar discusses the economic benefits of a single-payer system compared to the current multi-payer system, highlighting analyses showing that a single-payer system would lower overall healthcare costs while improving outcomes. Experts on the webinar address criticisms of single-payer and explain why the U.S. has not adopted such a system previously, noting the significant financial interests of private insurers and others that benefit from the current inefficient approach. The webinar aims to make the economic argument for why single-
Ethics are concerned with how we should live and make decisions regarding what is right and wrong. For PR professionals, making ethical decisions means balancing the public interest, their employer's interests, professional standards, and personal values. However, these areas often conflict, putting PR professionals in vague ethical situations like over-representing products or taking sides on issues that harm the environment. Professional codes of ethics from organizations like PRSA provide guidance, emphasizing values like advocacy, honesty, and fairness. Ultimately, PR professionals are expected to maintain personal ethics by being honest, respecting all parties, and balancing loyalty and duty.
Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma
This document summarizes key points from ExLPharma's 6th annual MSL Best Practices conference. It discusses the evolving role of medical science liaisons (MSLs) and how they can effectively educate healthcare providers while minimizing compliance risks. The role of MSLs is varied by company but generally involves building scientific relationships with key opinion leaders. The document provides guidance on developing standard operating procedures for MSLs, clarifying their reporting structure, compensation practices, involvement in clinical trials and interactions with sales representatives to reduce promotional concerns. It emphasizes the need for MSL training, oversight and auditing to ensure their activities remain focused on non-promotional scientific exchange.
Pam Randhawa has over 15 years of experience in healthcare and pharmaceutical industries. She is currently the VP of Strategic Development at Sermo, the largest online physician community in the US. She discusses Sermo's origins from an idea by Dr. Daniel Palestrant to connect doctors virtually. Sermo has grown to nearly 100,000 physician members through a business model that is acceptable to physicians without fees or advertising. Randhawa also outlines Sermo's funding history and describes how the platform allows doctors to discuss patients, share insights, and connect with pharmaceutical companies while avoiding some of the pitfalls of other online communities.
Cosmological argument essay Religious Studies - A Level A Levels AQA .... Explain the Cosmological argument for the existence of God. - A-Level .... Explain The Cosmological Argument For The Existence Of Essay .... Cosmological argument model essay: - Document in A Level and IB .... Explain aquinas cosmological argument essay. Explain Key Criticisms .... Cosmological argument essay. Cosmological Argument Essay RSS03 - A-Level Religious Studies .... Explain The Cosmological Argument - GCSE Religious Studies Philosophy .... Cosmological Argument Lesson: What is the Cosmological Argument .... Cosmological Argument Teaching Resources. Design/Cosmological argument Essay/RS/A Teaching Resources. Cosmological argument essay conclusion, The Cosmological Argument: The .... Outline the Cosmological Argument for the existence of God. - A-Level .... OCR Cosmological Argument Essay Teaching Resources. Cosmological Argument - Philosophy A Level. PPT - The Cosmological Argument PowerPoint Presentation, free download .... Cosmological Argument Introduction Resources Teaching Resources. Cosmological Arguments - YouTube. Essay cosmological argument - dissertationsmean.x.fc2.com. What are the key ideas of the cosmological argument? - A-Level .... The Cosmological Argument Poster Philosophy Challenge. In Defense of the Kalam Cosmological Argument Free Essay Example. Cosmological Argument ESSAY PLAN - OCR Religious Studies A Level NEW .... Introduction to the Cosmological Argument - Useful both GCSE A-level .... Cosmological Argument Essay A-Level Philosophy Teaching Resources. The Kalam Cosmological Argument Cosmological argument, Teleological .... THE COSMOLOGICAL ARGUMENT Cosmological argument, Teleological .... Cosmological ESSAY PLANS Arguments From Observation- Philosophy ... Cosmological Argument Essay Cosmological Argument Essay
This document profiles 100 people in the pharmaceutical industry who were selected as inspiring leaders. It is the first annual issue by PharmaVOICE magazine to honor those who have made significant contributions to different sectors of the industry through their leadership, passion and commitment. The profiles are grouped into categories including Commanders and Chiefs, Risk Takers, Researchers and Scientists, Practitioners, Brand Builders, Technologists, Mentors, and Change Agents. The issue aims to provide insights into what makes these individuals inspiring through both their professional accomplishments and personal qualities.
Discover the barriers holding companies back from having the diversified teams needed to boost their results, ignite innovation and excellence. Learn what can be done to bridge the gap.
Maximize your Share of the Multi-Billion Dollar Biosimilars MarketDyan Cornacchio
Experts are estimating the global biosimilars market to be worth more than $11 billion by 2021- now is the time to learn best practices and strategies to maximize your position in this robust market.
Whether you are on the innovator or biosimilar side, ACI’s 8th Annual Summit on Biosimilars (https://goo.gl/4mtUUF) will help you develop and protect your biologics portfolio as our stellar faculty of experts discuss these featured topics:
• Policy and Politics of Biosimilars under the New Administration
• Untangling the Inner Workings of IPRs for Biosimilars
• Shall we Dance: Mastering the “Steps” of the BPCIA while Avoiding Common Pitfalls
View Agenda - https://goo.gl/454z9D
Don’t miss your chance to grab a piece of this exponentially growing market and register today! Mention Registration Code: B00-658-LNK17 when registering!
The Future of Healthcare Reform Now and More Developments Dyan Cornacchio
This document advertises and provides an agenda for the American Conference Institute's 8th Annual Advanced Forum on Managed Care Disputes and Litigation conference taking place on May 2-3, 2017 in Philadelphia, PA. The conference will provide managed care organizations and their counsel with updates on recent litigation trends, strategies for managing risk adjustment and risk corridor litigation, best practices for avoiding false claims cases, and insights on preparing for changes under the Trump administration. Speakers will include litigators and in-house counsel from major health insurers such as Aetna, Anthem, Cigna, Florida Blue, and Humana. An interactive workshop on May 3rd will allow attendees to collaborate on strategies for adapting to uncertainty under the new
More Related Content
Similar to Agenda and Complete Speakers List for Women in Life Sciences Law
1. The document discusses gender diversity and equality in global companies using Merck as a case study. It examines the business case and evidence for promoting women in leadership and the workforce.
2. Data on women's representation in Merck's regions, industries, and roles is presented. Challenges and best practices are outlined around setting goals, understanding drivers of representation, and engaging both men and women.
3. The discussion focuses on internal priorities like culture, development, and flexibility, as well as external stakeholders and customers, with the goal of enhancing inclusion and accelerating women's leadership development.
A panel discussion on how to stop declining female sex ratioArchana Tandon
The document discusses a panel discussion on declining female sex ratio in India. It provides biographies of four panelists: Dr. Archana Tandon, Dr. Kusum Singhal, Dr. Charu Rawat Mittal, and Dr. Kusumlata Singhal. It outlines their educational qualifications and experience in obstetrics and gynecology. The panelists will discuss major causes of declining female sex ratio such as female feticide and infanticide. They will also contemplate why society does not want female children and how these problems can be addressed.
Making your way in the new pharma and biotech world - Sept 2010Jeffrey Boily
A panel of industry experts take a look at how you can survive in the
future world of pharma, especially if you've found yourself stranded at the manager
or director level.
This document profiles Jenny Lin, the COO and Board Director of CMIC, Inc. With over 25 years of experience in executive management and laboratory operations supporting drug research, Jenny has authored over 30 publications. As COO of CMIC, Jenny emphasizes that talent management is key to their success and that people are the most important asset of any business. CMIC delivers bioanalysis services for small molecules, large molecules, biomarkers and oligonucleotides in a flexible manner, ensuring high-quality data through diligent training and an excellent lab environment.
Introduce Yourself to the Company - Writing About Myself Sample and .... Business Essay | Essay on Business for Students and Children in English .... Best Essay Writing Company. Essay writing business. Essay on community service in high school / silkstudio.com.au. A Comprehensive Guide to Write a business essay - YouTube. Do you underline company names in an MLA-style essay? - Quora - How to .... Business essay examples. Business Essay 19/20 | Year 11 HSC - Business Studies | Thinkswap. Essay writing company reviews are the key inductions to select a good…. 002 Job Application Essay Template Sample Teaching ~ Thatsnotus. Tips to find Write my Essay Company. Standard Essay Format | ... Poster Company” Essay Format The following .... Business essay format example. Essay writing company. Features of best essay writing company. Employment Essay. Essay writing company reviews and comments - stntunsw.web.fc2.com. Business essay. Expository essay: How to begin a business essay. business essays samples - News. Business Essay Sample — Understanding Global Business. Best Essay Company. Professional essay writing company London UK quick essay writers — ww…. Custom essay writing company Durham | ThesisEssay76 - (2021). Frightening Essay Writing Company ~ Thatsnotus.
SGA Talent Present Women Leader From The Top BioTech & Pharma Companies. SGA Talent
This report is limited to only a few women leaders identified in a recent study SGA Talent completed last year. The comprehensive study was to identify, map, and profile leaders in the Biotechnology and Pharmaceutical Industries three levels down from the executive teams. It required the SGA Talent team to create organization charts, compare/contrast all identified to their peers, gather salary information and show diversity and inclusion metrics.
If you are looking for talent or intelligence in these industries, give us a call 518 843-4611.
This document summarizes a conference on pharmaceutical and medical device compliance in Latin America being held in Panama City, Panama from August 23-25, 2016. The conference will address critical challenges in the region related to corruption, bribery, and transparency. It will feature panels, keynote addresses, and breakout sessions on topics like compliance priorities, balancing sales and compliance, and interacting with healthcare professionals. Over 50 industry speakers from Latin America, the US, and Europe will participate. The conference is aimed at upgrading compliance programs amid increasing regulation in Latin America's growing pharmaceutical and medical device sectors.
Different hats, same needs: Marketing compliance from doctor’s office to boar...Prolifiq Software
This document discusses the need for good promotional practices across different constituencies in the healthcare industry. It begins by outlining what doctors, companies, and board members want, which is largely reliable information, sales, and avoiding issues. The document then provides four actionable strategies for implementing good promotional practices: 1) Transforming sales reps into information concierges, 2) Using content management systems, 3) Implementing good promotional practices, and 4) Forming and supporting initiatives to bridge information gaps. It emphasizes that good promotional practices protect all parties and should be systematically institutionalized.
SGA Talent Presents The Key Players In The Medical Device IndustrySGA Talent
Since inception, SGA Talent has been helping organizations build more inclusive work places by continuously promoting and emphasizing the need to require both talent pools and candidate pipelines include diversity. We believe part of our responsibility to our partners is to continuously remind them that workplace diversity starts with hiring and the importance of including diversity as part of their overall recruiting strategy. That said, as we continue with our mission we carry on with building and maintaining engaged talent communities that include diversity. Part of doing this includes building our knowledge base of industry leading companies and the talent in the many industries in which we compete, always highlighting women. Part of our strategy is to create monthly industry reports to help with achieving our goals. This month’s report focuses on the Medical Device Industry.
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREADPinky Fadullon
This document provides information about the 6th Annual Global Orphan Drug Conference and Expo taking place April 21-22, 2016 in Washington D.C. The conference will bring together stakeholders in the orphan drug industry including pharmaceutical companies, patient advocacy groups, regulators, payers, and investors. It will include keynote sessions, workshops on topics like market forecasting and commercialization, and networking opportunities. A pre-conference day of workshops is scheduled for April 20th.
The document announces the Pharmaceutical Leadership Summit 2010 conference to be held on June 25-26, 2010 in Mumbai, India. It will bring together leaders from top pharmaceutical companies to discuss important topics facing the industry such as healthcare reforms, marketing strategies, research and development, and building leadership. The summit aims to provide networking opportunities and insights from senior executives on tackling challenges in the evolving pharmaceutical landscape. It promises high-profile speakers from the government and major companies over the two-day agenda covering issues critical to pharmaceutical leadership.
The document announces the Pharmaceutical Leadership Summit 2010 conference to be held on June 25-26, 2010 in Mumbai, India. It will bring together over 60 speakers from top pharmaceutical companies to discuss important topics facing the industry such as healthcare reforms, leadership, innovation, marketing strategies, and opportunities in biotech. The two-day agenda outlines various keynote speeches and panel discussions to be delivered by industry experts and government leaders on these pivotal issues. The summit aims to provide networking opportunities and insights on best practices to help pharmaceutical professionals tackle challenges and guide their organizations successfully.
This document summarizes a webinar presented by the American Sustainable Business Council (ASBC) on the business case for a single-payer "Medicare for All" healthcare system in the United States. The webinar discusses the economic benefits of a single-payer system compared to the current multi-payer system, highlighting analyses showing that a single-payer system would lower overall healthcare costs while improving outcomes. Experts on the webinar address criticisms of single-payer and explain why the U.S. has not adopted such a system previously, noting the significant financial interests of private insurers and others that benefit from the current inefficient approach. The webinar aims to make the economic argument for why single-
This document summarizes a webinar presented by the American Sustainable Business Council (ASBC) on the business case for a single-payer "Medicare for All" healthcare system in the United States. The webinar discusses the economic benefits of a single-payer system compared to the current multi-payer system, highlighting analyses showing that a single-payer system would lower overall healthcare costs while improving outcomes. Experts on the webinar address criticisms of single-payer and explain why the U.S. has not adopted such a system previously, noting the significant financial interests of private insurers and others that benefit from the current inefficient approach. The webinar aims to make the economic argument for why single-
Ethics are concerned with how we should live and make decisions regarding what is right and wrong. For PR professionals, making ethical decisions means balancing the public interest, their employer's interests, professional standards, and personal values. However, these areas often conflict, putting PR professionals in vague ethical situations like over-representing products or taking sides on issues that harm the environment. Professional codes of ethics from organizations like PRSA provide guidance, emphasizing values like advocacy, honesty, and fairness. Ultimately, PR professionals are expected to maintain personal ethics by being honest, respecting all parties, and balancing loyalty and duty.
Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma
This document summarizes key points from ExLPharma's 6th annual MSL Best Practices conference. It discusses the evolving role of medical science liaisons (MSLs) and how they can effectively educate healthcare providers while minimizing compliance risks. The role of MSLs is varied by company but generally involves building scientific relationships with key opinion leaders. The document provides guidance on developing standard operating procedures for MSLs, clarifying their reporting structure, compensation practices, involvement in clinical trials and interactions with sales representatives to reduce promotional concerns. It emphasizes the need for MSL training, oversight and auditing to ensure their activities remain focused on non-promotional scientific exchange.
Pam Randhawa has over 15 years of experience in healthcare and pharmaceutical industries. She is currently the VP of Strategic Development at Sermo, the largest online physician community in the US. She discusses Sermo's origins from an idea by Dr. Daniel Palestrant to connect doctors virtually. Sermo has grown to nearly 100,000 physician members through a business model that is acceptable to physicians without fees or advertising. Randhawa also outlines Sermo's funding history and describes how the platform allows doctors to discuss patients, share insights, and connect with pharmaceutical companies while avoiding some of the pitfalls of other online communities.
Cosmological argument essay Religious Studies - A Level A Levels AQA .... Explain the Cosmological argument for the existence of God. - A-Level .... Explain The Cosmological Argument For The Existence Of Essay .... Cosmological argument model essay: - Document in A Level and IB .... Explain aquinas cosmological argument essay. Explain Key Criticisms .... Cosmological argument essay. Cosmological Argument Essay RSS03 - A-Level Religious Studies .... Explain The Cosmological Argument - GCSE Religious Studies Philosophy .... Cosmological Argument Lesson: What is the Cosmological Argument .... Cosmological Argument Teaching Resources. Design/Cosmological argument Essay/RS/A Teaching Resources. Cosmological argument essay conclusion, The Cosmological Argument: The .... Outline the Cosmological Argument for the existence of God. - A-Level .... OCR Cosmological Argument Essay Teaching Resources. Cosmological Argument - Philosophy A Level. PPT - The Cosmological Argument PowerPoint Presentation, free download .... Cosmological Argument Introduction Resources Teaching Resources. Cosmological Arguments - YouTube. Essay cosmological argument - dissertationsmean.x.fc2.com. What are the key ideas of the cosmological argument? - A-Level .... The Cosmological Argument Poster Philosophy Challenge. In Defense of the Kalam Cosmological Argument Free Essay Example. Cosmological Argument ESSAY PLAN - OCR Religious Studies A Level NEW .... Introduction to the Cosmological Argument - Useful both GCSE A-level .... Cosmological Argument Essay A-Level Philosophy Teaching Resources. The Kalam Cosmological Argument Cosmological argument, Teleological .... THE COSMOLOGICAL ARGUMENT Cosmological argument, Teleological .... Cosmological ESSAY PLANS Arguments From Observation- Philosophy ... Cosmological Argument Essay Cosmological Argument Essay
This document profiles 100 people in the pharmaceutical industry who were selected as inspiring leaders. It is the first annual issue by PharmaVOICE magazine to honor those who have made significant contributions to different sectors of the industry through their leadership, passion and commitment. The profiles are grouped into categories including Commanders and Chiefs, Risk Takers, Researchers and Scientists, Practitioners, Brand Builders, Technologists, Mentors, and Change Agents. The issue aims to provide insights into what makes these individuals inspiring through both their professional accomplishments and personal qualities.
Discover the barriers holding companies back from having the diversified teams needed to boost their results, ignite innovation and excellence. Learn what can be done to bridge the gap.
Similar to Agenda and Complete Speakers List for Women in Life Sciences Law (20)
Maximize your Share of the Multi-Billion Dollar Biosimilars MarketDyan Cornacchio
Experts are estimating the global biosimilars market to be worth more than $11 billion by 2021- now is the time to learn best practices and strategies to maximize your position in this robust market.
Whether you are on the innovator or biosimilar side, ACI’s 8th Annual Summit on Biosimilars (https://goo.gl/4mtUUF) will help you develop and protect your biologics portfolio as our stellar faculty of experts discuss these featured topics:
• Policy and Politics of Biosimilars under the New Administration
• Untangling the Inner Workings of IPRs for Biosimilars
• Shall we Dance: Mastering the “Steps” of the BPCIA while Avoiding Common Pitfalls
View Agenda - https://goo.gl/454z9D
Don’t miss your chance to grab a piece of this exponentially growing market and register today! Mention Registration Code: B00-658-LNK17 when registering!
The Future of Healthcare Reform Now and More Developments Dyan Cornacchio
This document advertises and provides an agenda for the American Conference Institute's 8th Annual Advanced Forum on Managed Care Disputes and Litigation conference taking place on May 2-3, 2017 in Philadelphia, PA. The conference will provide managed care organizations and their counsel with updates on recent litigation trends, strategies for managing risk adjustment and risk corridor litigation, best practices for avoiding false claims cases, and insights on preparing for changes under the Trump administration. Speakers will include litigators and in-house counsel from major health insurers such as Aetna, Anthem, Cigna, Florida Blue, and Humana. An interactive workshop on May 3rd will allow attendees to collaborate on strategies for adapting to uncertainty under the new
The document summarizes the results of a survey of attendees at an FCPA conference on how companies should handle various investigations and legal issues related to bribery and corruption. In one scenario, a majority of attendees thought a company conducting an internal investigation into alleged bribes should orally summarize evidence for government authorities rather than sharing documents. In another scenario, most attendees thought a company should notify Chinese authorities if US authorities subpoenaed data that contained Chinese state secrets.
American Conference Institute's 2nd Annual FCC Boot Camp Dyan Cornacchio
The document advertises and provides details about the FCC Boot Camp event on June 27-29, 2016. The event will provide an overview of FCC regulations and examine topics such as the Universal Service Fund, developing telecom businesses in Cuba, set-top box rules, and network neutrality. Pre-conference workshops on FCC regulatory law fundamentals and privacy/security rules are also advertised. The event will feature a faculty of top FCC experts to share their knowledge and insights.
ACI's 2nd Annual Women Leaders in Financial Services Law and ComplianceDyan Cornacchio
This document announces ACI's 2nd annual Women Leaders in Financial Services Law and Compliance Workshop from May 12-13, 2016 in New York City. The workshop aims to increase the prominence of women through substantive legal discussions, professional development, and networking opportunities. It will bring together women leaders from over 20 financial institutions and companies.
ACI's Global Encryption, Cloud & Cybersecurity Controls Dyan Cornacchio
This document advertises an encryption and cybersecurity conference that will provide government and industry updates on encryption regulations from the US and EU. It highlights that attendees will hear directly from government officials and regulators. The agenda also includes panels on implementing encryption controls and satisfying new Chinese regulations. The conference aims to help companies benchmark compliance strategies against industry peers.
This document provides an agenda for an FDA Boot Camp conference. It highlights several new and featured sessions, including a session on breaking FDA news and hot cases, a pre-conference workshop on FDA regulatory fundamentals, and two post-conference interactive working groups focusing on exclusivity disputes and marketing liability. The agenda has been reworked this year to provide both essential regulatory background and real-world application.
Ten brand new sessions led by in-house and Judges at ACI’s Drug and Med Litig...Dyan Cornacchio
The document announces 10 new sessions for the 2015 Drug & Medical Device Litigation conference happening in New York from December 2-4. The sessions will be led by in-house counsel and judges and were designed by an Advisory Board to be sophisticated, practical, and tailored for experts in the field. Attendees can view the full list of new sessions and register online at www.DrugandMed.com before November 6th to take advantage of the lowest rates.
Defending Weapons Offence Charges: Role of Mississauga Criminal Defence LawyersHarpreetSaini48
Discover how Mississauga criminal defence lawyers defend clients facing weapon offence charges with expert legal guidance and courtroom representation.
To know more visit: https://www.saini-law.com/
Matthew Professional CV experienced Government LiaisonMattGardner52
As an experienced Government Liaison, I have demonstrated expertise in Corporate Governance. My skill set includes senior-level management in Contract Management, Legal Support, and Diplomatic Relations. I have also gained proficiency as a Corporate Liaison, utilizing my strong background in accounting, finance, and legal, with a Bachelor's degree (B.A.) from California State University. My Administrative Skills further strengthen my ability to contribute to the growth and success of any organization.
Guide on the use of Artificial Intelligence-based tools by lawyers and law fi...Massimo Talia
This guide aims to provide information on how lawyers will be able to use the opportunities provided by AI tools and how such tools could help the business processes of small firms. Its objective is to provide lawyers with some background to understand what they can and cannot realistically expect from these products. This guide aims to give a reference point for small law practices in the EU
against which they can evaluate those classes of AI applications that are probably the most relevant for them.
Synopsis On Annual General Meeting/Extra Ordinary General Meeting With Ordinary And Special Businesses And Ordinary And Special Resolutions with Companies (Postal Ballot) Regulations, 2018
Genocide in International Criminal Law.pptxMasoudZamani13
Excited to share insights from my recent presentation on genocide! 💡 In light of ongoing debates, it's crucial to delve into the nuances of this grave crime.
Lifting the Corporate Veil. Power Point Presentationseri bangash
"Lifting the Corporate Veil" is a legal concept that refers to the judicial act of disregarding the separate legal personality of a corporation or limited liability company (LLC). Normally, a corporation is considered a legal entity separate from its shareholders or members, meaning that the personal assets of shareholders or members are protected from the liabilities of the corporation. However, there are certain situations where courts may decide to "pierce" or "lift" the corporate veil, holding shareholders or members personally liable for the debts or actions of the corporation.
Here are some common scenarios in which courts might lift the corporate veil:
Fraud or Illegality: If shareholders or members use the corporate structure to perpetrate fraud, evade legal obligations, or engage in illegal activities, courts may disregard the corporate entity and hold those individuals personally liable.
Undercapitalization: If a corporation is formed with insufficient capital to conduct its intended business and meet its foreseeable liabilities, and this lack of capitalization results in harm to creditors or other parties, courts may lift the corporate veil to hold shareholders or members liable.
Failure to Observe Corporate Formalities: Corporations and LLCs are required to observe certain formalities, such as holding regular meetings, maintaining separate financial records, and avoiding commingling of personal and corporate assets. If these formalities are not observed and the corporate structure is used as a mere façade, courts may disregard the corporate entity.
Alter Ego: If there is such a unity of interest and ownership between the corporation and its shareholders or members that the separate personalities of the corporation and the individuals no longer exist, courts may treat the corporation as the alter ego of its owners and hold them personally liable.
Group Enterprises: In some cases, where multiple corporations are closely related or form part of a single economic unit, courts may pierce the corporate veil to achieve equity, particularly if one corporation's actions harm creditors or other stakeholders and the corporate structure is being used to shield culpable parties from liability.
What are the common challenges faced by women lawyers working in the legal pr...lawyersonia
The legal profession, which has historically been male-dominated, has experienced a significant increase in the number of women entering the field over the past few decades. Despite this progress, women lawyers continue to encounter various challenges as they strive for top positions.
Agenda and Complete Speakers List for Women in Life Sciences Law
1. Register Now | 888 224 2480 | AmericanConference.com/LSWomen
a C5 Group Company
Business Information in a Global Context
1
ACIAmerican Conference Institute
Business Information in a Global Context
FIRESIDE CHAT
with Martine Rothblatt, PhD
CEO of United Therapeutics
Successful M&A Strategies
for All Practice Areas
Tips for Getting Ahead
in the Public and
Private Sectors
EARN CLE/ETHICS
CREDITS
Register now I 888-224-2480 I AmericanConference.com/LSWomen
4th
Annual Conference on
Women Leaders in
Life Sciences Law
July 19-21, 2017
The Hyatt Regency Boston
Boston, MA
Sponsored by:
2. Join the Conversation @ACI_Pharma #ACIWomeninLifeSciences ACI’s Women Leaders in Law Series2
Welcome Letter
Dear Colleague,
As women in the Life Sciences legal field, the need to work together to achieve success is becoming more
and more apparent each year. In 2016, nearly 200 women united at this event with a focus on camaraderie and
created a bond that lasted well beyond the three-day meeting. This year’s program brings together a speaker
faculty full of truly remarkable women who will come together to guide you through inspirational discussions,
substantive legal updates, and networking. Advice and strategies abound at this one-of-a-kind conference
designed specifically to address the needs of women trying to advance and thrive in the Life Sciences fields.
Kicking this year’s conference off, we start with the workshop, Networking as a Woman: Clear-Cut Tools
for EnhancingYour Experience and Making It Count - a perfect start to your conference experience with a
focus on networking and career development. Get the tools you need to take your conference experience to
the next level in this comprehensive new workshop. This is a can’t-miss opportunity for anyone looking to get
the most out of this event.
This conference is a great opportunity to step away from the demands of your day job and thoughtfully consider
your career plan amongst this group of exceptional women. Make sure you don’t miss out on this year’s
insightful discussions and meaningful connections that will allow your career to flourish when you put to work
the skills and lessons learned at this program.
Very truly yours,
Megan E. Furino, Esq.
Legal Conference Producer Advisory Board and In-House
insights from:
23andme
Abbott Laboratories
Acorda Therapeutics, Inc.
ARIAD Pharmaceuticals, Inc.
Astellas US LLC
Blueprint Medicines
Cantel Medical
Eisai Inc.
Eli Lilly and Company
EMD Serono, Inc.
GlaxoSmithKline
InVivo Therapeutics Corp.
Jounce Therapeutics
McKesson Corporation
Medtronic
Merck & Co., Inc.
Novo Nordisk
Pfizer, Inc.
Purdue Pharma L.P.
Ultragenyx
United Therapeutics
Vertex Pharmaceuticals
and many more...
If law firms and law departments are serious about developing women leaders,
then they’ll send them to this conference. The who’s who of health care lawyers are here
and there are multiple opportunities for informal networking and mentoring conversations.
Tamara Joseph, SVP, General Counsel, InVivo Therapeutics Corp.
“
3. Register Now | 888 224 2480 | AmericanConference.com/LSWomen
a C5 Group Company
Business Information in a Global Context
3
SUBSTANTIVE SESSIONS
GET LEGAL UPDATES ACROSS ALL PRACTICE AREAS
IN LIFE SCIENCES (PG. 6)
PRACTICAL STRATEGIES FOR GUIDINGYOUR COMPANY
THROUGH THE LATEST BUSINESS TRENDS (PG. 6)
TACTICS FOR COMING OUT UNSCATHED IN TUMULTUOUS
M&A SITUATIONS (PG. 5)
PREPARE FOR WHAT LIES AHEAD FOR LIFE SCIENCES
UNDER THE TRUMP ADMINISTRATION (PG. 6)
CONCRETE TOOLS FOR SUCCESS
WANT TO GET AHEAD? LEARN TECHNIQUES FOR
ADVANCING IN ANY SETTING (PG. 6)
Highlights of the 2017 Conference:
LEARN PROVEN TECHNIQUES FOR RETAINING
FEMALE TALENT (PG. 5-6)
HOW TO BECOME AN ALLY TO THE NEXT GENERATION
OF WOMEN (PG. 6)
POINTERS FROM THE PROS
BRAND NEW WORKSHOP – LEARN HOW TO NETWORK
FROM POWERHOUSE PROS (PG. 5)
JOIN MARTINE ROTHBLATT, CEO OF UNITEDTHERAPEUTICS
FOR A FIRESIDE CHAT (PG. 5)
TIPS FOR JOINING OR STARTING A WOMEN’S GROUP
AT YOUR ORGANIZATION (PG. 5)
Who are we?
This conference brings together in house and private practice professionals from the Pharmaceutical, Biotechnology,
and Medical Device industries, well-versed in patents, IP, fraud and abuse compliance/enforcement, products liability,
regulatory, M&A, and transactional law, and more providing most conducive setting for networking and career
development between female legal, business, and compliance professionals.
1
https://en.wikipedia.org/wiki/List_of_American_women’s_firsts
2
http://www.gapinc.com/content/dam/gapincsite/documents/MCCA_JulyAug_Book_Excerpt.pdf
3
http://www.americanbar.org/content/dam/aba/administrative/litigation/materials/2014_women/written_materials/p2_1_women_general_counsel_to_know.authcheckdam.pdf
4
http://www.americanbar.org/content/dam/aba/administrative/litigation/materials/2014_women/written_materials/p2_1_women_general_counsel_to_know.authcheckdam.pdf
5
http://www.americanbar.org/content/dam/aba/administrative/litigation/materials/2014_women/written_materials/p2_1_women_general_counsel_to_know.authcheckdam.pdf
6
http://www.catalyst.org/knowledge/women-ceos-sp-500
7
https://en.wikipedia.org/wiki/List_of_women_CEOs_of_Fortune_500_companies
Our mission:
ACI’s Women Leaders in Law series aims to promote diversity and increase the prominence of women in the legal
community through substantive legal discussion, professional development, and woman-to-woman networking.
Our conferences provide industry specific forums for female powerbrokers to unite and discuss the substantive legal
developments, challenges and opportunities facing women in their respective industries as well as provide them with the
business contacts and communication and leadership skills necessary for continued success and career advancement.
1870 1979 1999 2012 2013 2017
Ada Kepley
Mary Ann Hynes
is the first woman
to graduate from
law school in the
U.S.1
becomes the first
female GC of a
Fortune 500
company.2
44 women served
as General Counsel
to Fortune 500
Companies (8.8%).3
Women held 21%
of the GC and CLO
positions
in Fortune 500
Companies.4
Number of women
holding top legal
roles at Fortune 500
Companies declines
as female law
graduates and
practicing attorney
numbers are on
the rise.5
Women hold 5.4%
of CEO positions
in the S&P 500 and
only 4.6% of CEO
positions in the
Fortune 500.6 7
Timeline to the Top: Help us shape the future.
4. Join the Conversation @ACI_Pharma #ACIWomeninLifeSciences ACI’s Women Leaders in Law Series4
Advisory Board:
Christine Bellon
VP, Legal Affairs
Blueprint Medicines (Cambridge, MA)
Reza Green
Vice President, Intellectual Property
Novo Nordisk (Plainsboro, NJ)
Deborah A. Logan
Associate General Counsel
EMD Serono, Inc. (Rockland, MA)
Donna M. Meuth
Associate General Counsel
Intellectual Property
Eisai Inc. (Andover, MA)
Sally L. Maher
VP Regulatory Affairs &
Clinical Global Critical Care
Edwards Lifesciences (Irvine, CA)
Mary Z. Monovoukas
VP, Chief Global Regulatory &
Privacy Counsel
Boston Scientific (Marlborough, MA)
Elena Rossano
Assistant General Counsel
Purdue Pharma L.P. (Stamford, CT)
Marianne Slivkova
Director – Legal
Acorda Therapeutics, Inc. (Ardsley, NY)
Co-Chairs:
Elona Kogan
Former General Counsel and Senior Vice
President of Government Relations
ARIAD Pharmaceuticals, Inc.
Gael Tisack
Director of Technology Evaluation and
Industry Engagement
Wichita State University
Lori Cohen
Shareholder and Chair, Pharmaceutical,
Medical Device & Health Care Litigation
Practice
Greenberg Traurig, LLP
Speakers:
Rachel Adcox
Partner
Axinn, Veltrop & Harkrider LLP
(Washington, DC)
Corinne E. Atton
Associate
Fitzpatrick Cella Harper & Scinto
(New York, NY)
Michelle D. Axelrod
Principal
Porzio, Bromberg & Newman, P.C.
(Westborough, MA)
Anna Barry
Senior Vice President, Legal & Secretary
Jounce Therapeutics (Cambridge, MA)
Tracy Palmer Berns
VP, Ethics & Compliance
Medtronic, MITG (Mansfield, MA)
Sara Miron Bloom
Assistant United States Attorney
United States Attorney’s Office for the
District of Massachusetts (Boston, MA)
Delphine Knight Brown
Partner
Axinn, Veltrop & Harkrider LLP
(New York, NY)
Distinguished Faculty
Donna Meuth
Associate General Counsel
Intellectual Property
Eisai (Andover, MA)
Tiffany R. Moseley
Partner
Loeb & Loeb LLP (Washington, DC)
Mercedes Myer, Ph.D.
Partner
Drinker Biddle LLP (Washington, DC)
Amy Nelson, Ph.D.
Associate Solicitor
U.S. Patent and Trademark Office
(Alexandria, VA)
Sapna Palla
Partner
Wiggin & Dana (New York, NY)
Karah Parschauer
EVP, General Counsel
Ultragenyx Pharmaceutical
(Novato, CA)
Katie Pawlitz
Partner
Reed Smith LLP (Washington, DC)
Lisa J. Pirozzolo
Partner, Co-Chair Intellectual Property
Litigation Practice Group
Wilmer Cutler Pickering Hale and
Dorr LLP (Boston, MA)
Elena Rossano
Assistant General Counsel
Purdue Pharma L.P. (Stamford, CT)
Martine Rothblatt, PhD
Chairman & CEO
United Therapeutics (Silver Spring, MD)
Melanie Rupert
Partner, Litigation Department
Paul Hastings (New York, NY)
Alicia Russo
Partner
Fitzpatrick Cella Harper & Scinto
(New York, NY)
Jennifer Santos
Sr. Corporate Counsel
Vertex Pharmaceuticals (Boston, MA)
Sheila Swaroop
Partner
Knobbe, Martens, Olson & Bear, LLP
(Irvine, CA)
Michelle M. Umberger
Madison Office Managing Partner
Perkins Coie (Madison, WI)
Laura A. Vogel
Partner
Barclay Damon, LLP (Boston, MA)
Linda A. Wadler
Partner
Finnegan, Henderson, Farabow,
Garrett & Dunner, LLP
(Washington, DC)
Jane Wasman
President, International and
General Counsel
Acorda Therapeutics, Inc. (Ardsley, NY)
Sally Woodhouse
Vice President
Cornerstone Research (Boston, MA)
Maryana Zubok
Senior Corporate Counsel
Pfizer, Inc. (New York, NY)
Tonya L. Combs
Sr. Director - General Patent Counsel,
Lilly BioMedicines
Eli Lilly and Company (Indianapolis, IN)
Carol Pitzel Cruz
Partner
Knobbe, Martens, Olson & Bear, LLP
(Seattle, WA)
Megan D’Alisera
Senior Counsel
Cantel Medical (New York, NY)
Gail L. Daubert
Partner
Reed Smith LLP (Washington, DC)
Courtney Camp Enloe
Chief Counsel
Manufacturing Relationships
McKessonCorporation(SanFrancisco,CA)
Elizabeth Feeney
Assistant General Counsel
Dispute Resolution & Prevention
GlaxoSmithKline
(Philadelphia, PA)
Lorie S. Foster
Division Counsel
Abbott Laboratories (Columbus, OH)
Linda Friedman
Executive Vice President
General Counsel
Astellas US LLC (Northbrook, IL)
Kathleen Gersh
Senior Counsel
Loeb & Loeb LLP (New York, NY)
Megan Grossman
Shareholder
Segal McCambridge Singer
& Mahoney, Ltd (Philadelphia, PA)
Colleen Hennessey
Managing Partner
Peabody & Arnold LLP (Boston, MA)
Kathy Hibbs
General Counsel
23andme (Mountain View, CA)
Ellen Hudock
Anti-Bribery &
Corruption Investigations Counsel
GlaxoSmithKline (Philadelphia, PA)
Tamara Joseph
SVP, General Counsel &
Chief Compliance Officer
InVivo Therapeutics Corp.
(Cambridge, MA)
Catherine B. Levitt
Vice President, Regional General Counsel
and Secretary, Americas
Astellas US LLC (Northbrook, IL)
Diane E. Lifton
Partner and Co-Chair, Life Sciences Group
Product Liability Group and Co-Chair of
Hiring and Diversity Committees
Hughes Hubbard & Reed LLP
(New York, NY)
Deborah A. Logan
Associate General Counsel
EMD Serono, Inc. (Rockland, MA)
Maureen McGirr
Vice President
Office of Ethics, Global Compliance
Merck & Co., Inc. (North Wales, PA)
Monique Hunt McWilliams
Chief Diversity Officer
Eli Lilly and Company (Indianapolis, IN)
5. Register Now | 888 224 2480 | AmericanConference.com/LSWomen
a C5 Group Company
Business Information in a Global Context
5
1:30 – 4:30 (Registration begins at 1 pm)
Workshop A: Networking as a Woman: Clear-Cut Tools for
Enhancing Your Experience and Making It Count
Tracy Palmer Berns
VP, Ethics & Compliance
Medtronic, MITG (Mansfield, MA)
Linda Friedman
Executive Vice Presiden
General Counsel
Astellas US LLC (Northbrook, IL)
Elena Rossano
Assistant General Counsel
Purdue Pharma L.P. (Stamford, CT)
Laura A. Vogel
Partner
Barclay Damon, LLP (Boston, MA)
• Tips for starting the conversation and making yourself memorable
• Using social media to network effectively
• Strategies for building your resume and getting on boards
• Plans for creating a pipeline of women coming up through the ranks
• Learn how to concisely and effectively introduce a peer and highlight her
achievements, talents, and abilities to other peers, employers, and clients
• Pair up with a partner to practice tools designed to enhance your skills
as a mentor or mentee
4:45 Day 1 Adjourns to Pre-Registration and Welcoming
Reception Hosted by
7:15 Registration and Continental
Breakfast Hosted by
8:15 Women Leaders in Life Sciences Law Empowerment
Awards Ceremony
8:30 Co-Chairs’ Introductory Remarks andWelcoming Exercise
Elona Kogan
Former General Counsel and
Senior Vice President of
Government Relations
ARIAD Pharmaceuticals, Inc.
(Cambridge, MA)
Gael Tisack
Director of Technology
EvaluationandIndustryEngagement
Wichita State University
(Wichita, KS)
Lori Cohen
Shareholder and Chair
Pharmaceutical, Medical Device
& Health Care Litigation Practice
Greenberg Traurig, LLP
(Atlanta, GA)
In this session, attendees will break into small groups at their tables as our
conference leaders take you through an icebreaking exercise.
9:00 Fireside Chat with Martine Rothblatt, PhD
Chairman & CEO of United Therapeutics
Interviewed by
Lori Cohen, Shareholder and Chair, Pharmaceutical, Medical Device &
Health Care Litigation Practice at GreenbergTraurig, LLP
9:30 Year in Review:2016-2017 Legal Updates by PracticeArea
Kathleen Gersh
Senior Counsel
Loeb & Loeb LLP (New York, NY)
Colleen Hennessey
Managing Partner
Peabody & Arnold LLP
(Boston, MA)
Katie Pawlitz, Partner
Reed Smith LLP (Washington, DC)
Melanie Rupert, Partner
Litigation Department
Paul Hastings LLP (New York, NY)
Sally Woodhouse
Vice President
Cornerstone Research (Boston, MA)
Speakers will review the most important case law updates and enforcement
initiatives of the past year that every Life Sciences professional needs to know.
Broken down by practice area, including IP, Products Liability, and Compliance,
this session will provide attendees with the big picture of the year’s most critical
developments giving you the competitive edge you need to advance in your field.
11:00 Networking Break
11:30 Women’s Leadership Initiative: Creating and
Maintaining Successful Female Groups
Courtney Camp Enloe
Chief Counsel
Manufacturing Relationships
McKesson Corporation
(San Francisco, CA)
Monique Hunt McWilliams
Chief Diversity Officer
Eli Lilly and Company
(Indianapolis, IN)
Jennifer Santos
Sr. Corporate Counsel
VertexPharmaceuticals(Boston,MA)
Mercedes Myer, Ph.D.
Partner
Drinker Biddle LLP
(Washington, DC)
Lisa J. Pirozzolo
Partner, Co-Chair Intellectual Property
Litigation Practice Group
Wilmer Cutler Pickering Hale and
Dorr LLP (Boston, MA)
• Taking a hard look at the statistics regarding the representation of
women in the life sciences legal industry
• Understanding the business imperatives behind diversity and
inclusion: building corporate and law firm buy-in
• Designing and carrying out practices to ensure that traditionally
underrepresented groups have a path to success
• Educating yourself on unconscious bias and being objective about
what is happening
• Identifying and participating in external groups including
associations, mentoring and groups by common interests
• Discussing which diversity initiatives are working, which aren’t, and why
• Learning ways to keep your group thriving by evolving and changing
with the needs of its members
12:45 Networking Lunch for Speakers and Attendees
2:00 M&A in the Life Sciences Industry:
Impacts from Antitrust to IP and Beyond
Elona Kogan
Former General Counsel and
Senior Vice President of
Government Relations
ARIAD Pharmaceuticals, Inc.
(Cambridge, MA)
Donna Meuth
Associate General Counsel
Intellectual Property
Eisai (Andover, MA)
Rachel Adcox
Partner
Axinn, Veltrop & Harkrider LLP
(Washington, DC)
Alicia Russo
Partner
Fitzpatrick Cella Harper & Scinto
(New York, NY)
With M&A on the rise in the Life Sciences Industry, nearly every professional
in this industry will be affected by it at some point. Our experienced panelists
will help you understand the far-reaching impacts of these transactions and
how those in other practice areas will be impacted. In addition, they will review
strategies for avoiding common pitfalls and balancing your own interests with
the interests of the company.
3:15 Peer-to-Peer Networking Break
3:30 Retaining Women in the Workplace
Michelle D. Axelrod
Principal
Porzio, Bromberg & Newman,
P.C (Westborough, MA)
Elizabeth Feeney
Assistant General Counsel
Dispute Resolution & Prevention
GlaxoSmithKline
(Philadelphia, PA)
Ellen Hudock
Anti-Bribery
Corruption Investigations Counsel
GlaxoSmithKline
(Philadelphia, PA)
Sheila Swaroop
Partner
Knobbe, Martens, Olson &
Bear LLP (Irvine, CA)
Linda A. Wadler
Partner
Finnegan, Henderson, Farabow,
Garrett & Dunner, LLP
(Washington, DC)
• Learning active steps firms and companies can take to retain strong
female talent
• Giving women crucial tools they can use to be successful and keep
their careers moving forward
Day 1,Thursday, July 20, 2017
Wednesday, July 19, 2017
Pre-Conference Workshop
6. Join the Conversation @ACI_Pharma #ACIWomeninLifeSciences ACI’s Women Leaders in Law Series6
• Exploring some of the challenges faced by women seeking pay
equity and leadership roles at Life Sciences companies and the
firms representing them
• Advocating for yourself and getting credit for your contributions
and achievements
• Techniques for increasing awareness of exceptional work done by
women at your company
4:45 Latest Business Initiatives and Their Legal Implications
Martine Rothblatt, PhD
Chairman & CEO
United Therapeutics
(Silver Spring, MD)
Maryana Zubok
Senior Corporate Counsel
Pfizer, Inc. (New York, NY)
Gail L. Daubert, Partner
Reed Smith LLP
(Washington, DC)
Lorie S. Foster
Division Counsel
Abbott Laboratories
(Columbus, OH)
Sapna Palla
Partner
Wiggin & Dana
(New York, NY)
In this session, our panelists will discuss some of the recent business trends
within the Life Sciences industry, how they may impact your company and
what attorneys need to know to best counsel their clients or colleagues.
Such topics covered will include:
• Patient-centered care
• Access and pricing initiatives
• Business initiatives under the First Amendment umbrella
• The business and strategic portfolio management of life sciences patents
• Reimbursement including coding, coverage, and payment in an
evolving environment
5:45 Day 1 Adjourns to
Reception Hosted by
7:30 Continental Breakfast
Hosted by
8:15 Co-Chairs’ Opening Remarks and Recap of Day 1
8:30 Women Leaders in the Public Sector:
2017 Priorities and the Unique Obstacles They Face
Sara Miron Bloom
Assistant United States Attorney
United States Attorney’s Office
for the District of Massachusetts
(Boston, MA)
Amy Nelson, Ph.D.
Associate Solicitor
U.S. Patent and Trademark
Office (Alexandria, VA)
Gael Tisack
Director of Technology Evaluation
and Industry Engagement
Wichita State University
(Wichita, KS)
Do not miss this unique opportunity to gain insights from some of the most
influential women leaders in the public sector as they discuss their top
priorities life sciences industry for 2017, differences from the public sector,
and what those in the private sector need to know. Moreover, learn about
their career paths and how to succeed in the public sector.
9:30 Trump Administration: Keeping Ahead of the Changes
Delphine Knight Brown
Partner
Axinn, Veltrop & Harkrider LLP
(New York, NY)
Megan Grossman
Shareholder
Segal McCambridge
Singer & Mahoney, Ltd (Philadelphia, PA)
In 2017, Life Sciences companies and their counsel will need to deal with
myriad change to regulatory agencies, including the USPTO and FDA
as well the DOJ’s latest enforcement priorities under the country’s new
administration. Hear from leading women in the know about how to prepare
for the upcoming changes and learn the information you need to become the
source for strategies to adapt to these changes at your company or firm.
10:30 Peer to Peer Mingling Break
11:00 NextGen in the Life Sciences Legal Industry:
Assets and Challenges
Megan D’Alisera
Senior Counsel
Cantel Medical
(New York, NY)
Corinne E. Atton
Associate
Fitzpatrick Cella Harper &
Scinto (New York, NY)
Join our panel of NextGen legal professionals as they discuss some of
the unique challenges they are facing in their careers and what higher
ups need to know to help women succeed in today’s environment.
Our panelists will also discuss some of the differences of NextGen
professionals and how these can make them an asset in the workplace.
11:45 Getting Ahead:Tips for Reaching the Top in
Public Sector, Law Firms, and Corporations
Anna L. Barry
Senior Vice President
Legal & Secretary
Jounce Therapeutics, Inc.
(Cambridge, MA)
Deborah A. Logan
Associate General Counsel
EMD Serono, Inc.
(Rockland, MA)
Maureen McGirr
Vice President, Office of Ethics
Global Compliance
Merck & Co., Inc. (North Wales, PA)
Michelle M. Umberger
Madison Office Managing Partner
Perkins Coie
(Madison, WI)
Moderated by:
Carol Pitzel Cruz
Partner
Knobbe, Martens, Olsen &
Bear LLP (Seattle, WA)
Featuring panelists with diverse experiences and backgrounds, this
session is designed to provide tips to help women advance their career.
Whether you are at a big firm, small firm, in house, not-for-profit, or somewhere
else, this is the must-attend panel that will give you the tools you need
break the glass ceiling and reach the top in your chosen field.
12:30 – Lunch for Workshop Attendees Only
1:30 - 4:30
Workshop B:“What I Wish I Had Known”:Advice from
Inspiring and Influential Life Sciences General Counsel
Tonya L. Combs
Sr. Director - General Patent
Counsel, Lilly BioMedicines
Eli Lilly and Company
(Indianapolis, IN)
Kathy Hibbs
General Counsel
23andme (Mountain View, CA)
Tamara Joseph
SVP, General Counsel &
Chief Compliance Officer
InVivo Therapeutics Corp.
(Cambridge, MA)
Catherine B. Levitt
Vice President, Regional General
Counsel and Secretary, Americas
Astellas US LLC (Northbrook, IL)
Karah Parschauer
EVP, General Counsel
Ultragenyx Pharmaceutical
(Novato, CA)
Jane Wasman
President, International and
General Counsel
Acorda Therapeutics, Inc.
(Ardsley, NY)
Moderated by:
Diane E. Lifton
Partner and Co-Chair
Life Sciences Group
Product Liability Group
and Co-Chair of Hiring and
Diversity Committees
Hughes Hubbard & Reed LLP
(New York, NY)
Back for the fourth year by popular demand, this event highlight is a can’t
miss ending to an incredible conference. Don’t skip this opportunity to
network with and learn from an unparalleled panel of General Counsel
driving changes and delivering results in the life sciences world who will
provide mentoring and guidance for women at all stages in their career
on advancing within the ranks of the life sciences world. The esteemed
panelists will share their road to the GC office, advice for shattering the
glass ceiling, skills necessary to thrive at the executive level, what they
look for in relationships with outside counsel and with their legal teams,
and balancing management of a successful department with a robust
and full personal life.
Day 2, Friday, July 21, 2017
Post-Conference Workshop
Tiffany R. Moseley
Partner
Loeb & Loeb LLP
(Washington, DC)
8. 8
B00-684-684L17.E
REGISTRATION CODE
Attention Mailroom
If undeliverable to addressee, please forward to:
General Counsel; Chief Compliance Officer;
Managing Partner; Chief Diversity Counsel;
Corporate Counsel; Litigation/Legal Department
Incorrect Mailing Information
If you would like us to change any of your details,
please email Data@AmericanConference.com
or fax the label on this brochure to 1-877-927-1563.
American Conference Institute
45 West 25th
Street, 11th
Floor
New York, NY 10010
ACIAmerican Conference Institute
Business Information in a Global Context
•• Join Martine Rothblatt, PhD, Chairman & CEO of
United Therapeutics for a Fireside Chat (Pg. 5)
•• Develop a Thriving Women’s Group at Your Organization (Pg. 5)
•• Get the Tools You Need to Make Your Next M&A Successful (Pg. 5)
•• Learn How to Retain Strong Female Talent (Pg. 5-6)
•• Start Your Conference Experience Off on the Right Foot at our BRAND NEW
Workshop - Networking as a Woman - Led by Powerhouse Pros (Pg. 6)
Inside You’ll Find:
4th
Annual Conference on
Women Leaders in
Life Sciences Law
4th
Annual Conference on
Women Leaders in
Life Sciences Law
July 19-21, 2017
The Hyatt Regency Boston
Boston, MA
EARN CLE/ETHICS
CREDITS
July 19-21, 2017
The Hyatt Regency Boston, Boston, MA